Analysts: Isis Pharmaceuticals Inc (ISIS.OQ)
ISIS.OQ on NASDAQ Stock Exchange Global Select Market
28.87USD
11:19am EDT
28.87USD
11:19am EDT
Price Change (% chg)
$-0.42 (-1.43%)
$-0.42 (-1.43%)
Prev Close
$29.29
$29.29
Open
$29.08
$29.08
Day's High
$29.18
$29.18
Day's Low
$28.73
$28.73
Volume
69,615
69,615
Avg. Vol
507,698
507,698
52-wk High
$34.30
$34.30
52-wk Low
$7.55
$7.55
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Hold | -0.28 | December | 2 Aug 2013 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 1 | 1 | 2 | 2 |
| (2) OUTPERFORM | 3 | 3 | 2 | 2 |
| (3) HOLD | 3 | 4 | 4 | 4 |
| (4) UNDERPERFORM | 1 | 0 | 0 | 0 |
| (5) SELL | 1 | 1 | 1 | 1 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 2.78 | 2.67 | 2.56 | 2.56 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 9 | 18.38 | 29.70 | 10.38 | 24.14 |
| Quarter Ending Dec-13 | 9 | 31.25 | 95.40 | 15.50 | 25.59 |
| Year Ending Dec-13 | 9 | 119.72 | 170.10 | 91.40 | 112.20 |
| Year Ending Dec-14 | 9 | 115.96 | 177.75 | 70.90 | 151.48 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | 9 | -0.28 | -0.19 | -0.37 | -0.32 |
| Quarter Ending Dec-13 | 9 | -0.19 | 0.32 | -0.34 | -0.33 |
| Year Ending Dec-13 | 9 | -0.70 | -0.28 | -0.99 | -0.93 |
| Year Ending Dec-14 | 9 | -0.81 | -0.06 | -1.33 | -0.50 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Mar-13 | 45.24 | 43.36 | 1.88 | 4.16 |
| Quarter Ending Dec-12 | 15.78 | 19.87 | 4.09 | 25.93 |
| Quarter Ending Sep-12 | 23.11 | 11.60 | 11.51 | 49.81 |
| Quarter Ending Jun-12 | 40.06 | 47.34 | 7.28 | 18.17 |
| Quarter Ending Mar-12 | 22.72 | 23.24 | 0.52 | 2.27 |
| Earnings (per share) | ||||
| Quarter Ending Mar-13 | -0.02 | -0.03 | 0.01 | -22.95 |
| Quarter Ending Dec-12 | -0.23 | -0.23 | 0.00 | -1.95 |
| Quarter Ending Sep-12 | -0.26 | -0.33 | 0.07 | -25.33 |
| Quarter Ending Jun-12 | -0.09 | -0.01 | 0.08 | -88.24 |
| Quarter Ending Mar-12 | -0.26 | -0.24 | 0.02 | -7.26 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Sep-13 | 18.38 | 18.38 | 18.38 | 16.97 | 24.14 |
| Quarter Ending Dec-13 | 31.25 | 31.25 | 31.25 | 31.25 | 25.59 |
| Year Ending Dec-13 | 119.72 | 119.72 | 118.61 | 116.88 | 112.20 |
| Year Ending Dec-14 | 115.96 | 115.96 | 115.96 | 112.24 | 151.48 |
| Earnings (per share) | |||||
| Quarter Ending Sep-13 | -0.28 | -0.28 | -0.28 | -0.29 | -0.32 |
| Quarter Ending Dec-13 | -0.19 | -0.19 | -0.19 | -0.19 | -0.33 |
| Quarter Ending Dec-13 | -0.70 | -0.70 | -0.71 | -0.73 | -0.93 |
| Quarter Ending Dec-14 | -0.81 | -0.81 | -0.81 | -0.81 | -0.50 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 1 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 1 |
| Year Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-14 | 0 | 0 | 1 | 0 |
| Earnings | ||||
| Quarter Ending Sep-13 | 0 | 0 | 0 | 0 |
| Quarter Ending Dec-13 | 0 | 0 | 0 | 0 |
| Year Ending Dec-13 | 0 | 0 | 1 | 0 |
| Year Ending Dec-14 | 0 | 0 | 1 | 0 |
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$58.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Earnings vs.
Estimates